What is the expected growth forecast for the Non-Invasive Vagus Nerve Stimulation Device market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Non-Invasive Vagus Nerve Stimulation Device market?

Increasing demand for non-invasive treatments and technological advancements are key drivers.

What are the major challenges facing the Non-Invasive Vagus Nerve Stimulation Device market?

High development costs and regulatory hurdles are major challenges for market players.

Which regions are leading the Non-Invasive Vagus Nerve Stimulation Device market?

North America and Europe are currently leading the market due to high adoption rates.

Who are the top companies in the Non-Invasive Vagus Nerve Stimulation Device market?

Key players include major medical device manufacturers and innovative startups.

What future opportunities exist in the Non-Invasive Vagus Nerve Stimulation Device market?

Expanding applications in new therapeutic areas and emerging markets offer future opportunities.

How will technology impact the future outlook of the Non-Invasive Vagus Nerve Stimulation Device market?

Advances in device design and stimulation techniques will drive market growth and innovation.

What is the current regulatory landscape for the Non-Invasive Vagus Nerve Stimulation Device market?

Regulatory frameworks vary by region, with ongoing efforts to standardize and clarify guidelines.

How will the Non-Invasive Vagus Nerve Stimulation Device market size evolve in the next 5 years?

The market is expected to reach USD 2.5 billion by 2028, driven by increasing adoption and demand.

Non-Invasive Vagus Nerve Stimulation Device Value Chain Analysis & Forecast Outlook 2033

Non-Invasive Vagus Nerve Stimulation Device by Application (Hospitals, Ambulatory Surgical Centers, Others), by Types (Depression, Epilepsy, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Non-Invasive Vagus Nerve Stimulation Device Market Size | CAGR 15.2 Forecast 2033

Non-Invasive Vagus Nerve Stimulation Device Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Non-Invasive Vagus Nerve Stimulation Device Market Overview

The Non-Invasive Vagus Nerve Stimulation Device market refers to the industry that develops and manufactures devices used to stimulate the vagus nerve without invading the body. As the Non-Invasive Vagus Nerve Stimulation Device market size is expected to grow significantly, the growth outlook and market forecast are crucial for industry players to understand the industry expansion. The scope of this market includes Transcutaneous Vagus Nerve Stimulation (tVNS) devices and other non-invasive technologies. The current Non-Invasive Vagus Nerve Stimulation Device market size is approximately $123 million. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 8.5% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of neurological disorders and the growing demand for non-invasive treatments.

Loading chart…

Key forces shaping the industry include technology shifts towards more advanced and portable devices, regulations such as FDA approvals, and consumer behavior driving the demand for non-invasive treatments. The largest region in the Non-Invasive Vagus Nerve Stimulation Device market is North America, while the fastest-growing region is Asia-Pacific. As the market continues to grow, industry players must stay informed about the latest trends and developments to remain competitive. The Non-Invasive Vagus Nerve Stimulation Device market is expected to experience significant industry expansion in the coming years, driven by the growing demand for non-invasive treatments and the increasing adoption of transcutaneous vagus nerve stimulation devices.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cyberonics; Spark Biomedical; Nevro Corporation; Galvani Bioelectronics; Setpoint; Electrocore; Livanova; MicroTransponder; CVRx; Beijing PINS Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-Invasive Vagus Nerve Stimulation Device market is experiencing significant growth, driven by increasing demand for non-invasive treatments and advancements in technology. The market dynamics are influenced by various factors, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Increasing prevalence of neurological disorders, such as epilepsy and depression, is driving the demand for Non-Invasive Vagus Nerve Stimulation Device market. This, in turn, is expected to contribute to the growth forecast of the market.

Advances in technology, such as the development of portable and user-friendly devices, are expanding the Non-Invasive Vagus Nerve Stimulation Device market size and increasing its adoption rate.

Restraints2 items

High costs associated with Non-Invasive Vagus Nerve Stimulation Device market devices and treatments are limiting their adoption, particularly in developing countries with limited healthcare budgets.

Stringent regulatory requirements and the need for clinical trials to demonstrate the efficacy and safety of these devices are restraining the growth of the Non-Invasive Vagus Nerve Stimulation Device market.

Opportunities2 items

The growing awareness of the benefits of non-invasive treatments and the increasing demand for minimally invasive procedures are creating opportunities for the Non-Invasive Vagus Nerve Stimulation Device market to expand into new applications and industries.

Partnerships and collaborations between manufacturers, researchers, and healthcare providers are expected to drive innovation and increase the Non-Invasive Vagus Nerve Stimulation Device market size.

Challenges2 items

The Non-Invasive Vagus Nerve Stimulation Device market faces challenges related to reimbursement and insurance coverage, which can limit patient access to these treatments.

The market is also subject to intense competition, with several manufacturers offering similar products, which can make it difficult for companies to differentiate their products and maintain market share, ultimately affecting the growth forecast of the market.

Market Segmentation

Loading chart…

The Non-Invasive Vagus Nerve Stimulation Device market can be segmented based on application, which includes epilepsy, depression, and other applications. The application segment contributes to the overall market size by catering to different patient needs. For instance, the epilepsy segment holds a significant share due to the high prevalence of the disease and the effectiveness of Non-Invasive Vagus Nerve Stimulation Devices in reducing seizure frequency. Understanding the Non-Invasive Vagus Nerve Stimulation Device segmentation is crucial for market players to develop targeted strategies and capitalize on emerging opportunities.

The types segment of the Non-Invasive Vagus Nerve Stimulation Device market includes transcutaneous and transmucosal subtypes. Each subtype has its own set of advantages and disadvantages, influencing the overall market size. The transcutaneous subtype is further divided into gammaCore and NEMOS, while the transmucosal subtype includes monopolar and bipolar devices. Analyzing the market taxonomy of Non-Invasive Vagus Nerve Stimulation Devices helps industry stakeholders to identify areas of growth and make informed decisions.

Non-Invasive Vagus Nerve Stimulation Device Segmentation Breakdown8 items

Application

Hospitals

Ambulatory Surgical Centers

Others

Types

Depression

Epilepsy

Others

Regional Insights

Loading chart…

The Non-Invasive Vagus Nerve Stimulation Device market growth is anticipated to be driven by various regional factors. North America is expected to be the largest region, accounting for approximately 40% of the market share, driven by key drivers such as adoption of advanced medical technologies, investments in healthcare infrastructure, and a mature ecosystem.

The fastest-growing region is expected to be Asia Pacific, driven by factors such as demographics, with a growing population and increasing healthcare needs, policies supporting the development of medical technologies, and infrastructure investments in healthcare facilities. Europe is also expected to contribute significantly to the market growth, with key drivers including adoption of non-invasive treatments and investments in research and development.

Latin America and Middle East & Africa are also expected to contribute to the market growth, with key drivers including adoption of non-invasive treatments and investments in healthcare infrastructure. The regional forecast indicates that the market will experience significant growth in the coming years, driven by these regional factors.

Competitive Landscape

The Non-Invasive Vagus Nerve Stimulation Device market is moderately consolidated, driven by a mix of global players and local companies. The Non-Invasive Vagus Nerve Stimulation Device competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies concentrate on pricing and distribution.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. Key players in the market include:

Cyberonics: regional expansion

Spark Biomedical: innovation pipeline

Nevro Corporation: premium pricing

Galvani Bioelectronics: local manufacturing

Setpoint: OEM tie-ups

Electrocore: vertical integration

Key Non-Invasive Vagus Nerve Stimulation Device Companies10 items

Cyberonics

Spark Biomedical

Nevro Corporation

Galvani Bioelectronics

Setpoint

Electrocore

Livanova

MicroTransponder

CVRx

Beijing PINS Medical

Market Ecosystem

The Non-Invasive Vagus Nerve Stimulation Device ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. The ecosystem's boundaries are defined by the interactions between these stakeholders, where value is created and captured through the development, manufacturing, and distribution of non-invasive vagus nerve stimulation devices.

Raw material/component suppliers — providing essential components

OEMs / manufacturers — designing and producing devices

Technology providers — developing underlying technologies

System integrators / EPCs — integrating devices into healthcare systems

Distributors / channel partners — delivering devices to end users

Service providers / after-sales — offering maintenance and support services

Regulators/standards bodies — establishing safety and efficacy standards

The flow of value in the Non-Invasive Vagus Nerve Stimulation Device ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact adoption rates. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit, while regional differences in healthcare systems and regulations can lead to variations in the ecosystem's structure and dynamics, highlighting the need for a thorough value chain analysis.

Recent Industry Insights

The Non-Invasive Vagus Nerve Stimulation Device industry has witnessed significant developments over the last 12-18 months, shaping Non-Invasive Vagus Nerve Stimulation Device industry trends. Notable partnerships between key players have accelerated innovation, while mergers and acquisitions have led to consolidation and expanded market reach. Recent product launches have also showcased advancements in technology, enhancing treatment outcomes and patient experiences.

Furthermore, regulatory changes have created new opportunities for market growth, and shifts in consumer preferences have driven demand for more personalized and non-invasive treatment options. The industry has also seen significant funding rounds, enabling companies to invest in research and development, and driving further expansion in the market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Non-Invasive Vagus Nerve Stimulation Device market outlook. The market exhibits high attractiveness due to its potential to treat various neurological and psychiatric disorders. The competitive intensity is moderate, with key players investing in research and development to improve device efficacy and user experience.

The long-term outlook for the Non-Invasive Vagus Nerve Stimulation Device market is promising, driven by increasing demand for non-invasive treatments and advancements in innovation landscape. However, the demand–supply balance may be affected by key risk factors, such as regulatory challenges and high development costs. Overall, the market is expected to experience steady growth, with opportunities for new entrants and established players to capitalize on the growing demand for non-invasive vagus nerve stimulation devices.

11 items

1. Executive Summary

2. Non-Invasive Vagus Nerve Stimulation Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-Invasive Vagus Nerve Stimulation Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Non-Invasive Vagus Nerve Stimulation Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Ambulatory Surgical Centers

6.1.3. Others

6.2. Global Non-Invasive Vagus Nerve Stimulation Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Depression

6.2.2. Epilepsy

6.2.3. Others

6.3. Global Non-Invasive Vagus Nerve Stimulation Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Non-Invasive Vagus Nerve Stimulation Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-Invasive Vagus Nerve Stimulation Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-Invasive Vagus Nerve Stimulation Device Market Competition by Key Manufacturers

8.1. Global Non-Invasive Vagus Nerve Stimulation Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Non-Invasive Vagus Nerve Stimulation Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Cyberonics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Spark Biomedical

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Nevro Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Galvani Bioelectronics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Setpoint

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Electrocore

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Livanova

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. MicroTransponder

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. CVRx

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Beijing PINS Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-Invasive Vagus Nerve Stimulation Device Market

Figure 4: Global Non-Invasive Vagus Nerve Stimulation Device Market: Drivers

Figure 5: Global Non-Invasive Vagus Nerve Stimulation Device Market: Challenges

Figure 6: Global Non-Invasive Vagus Nerve Stimulation Device Market: Trends

Figure 7: Global Non-Invasive Vagus Nerve Stimulation Device Market: Opportunity

Figure 8: Global Non-Invasive Vagus Nerve Stimulation Device Market: Restraint

Figure 9: Global Non-Invasive Vagus Nerve Stimulation Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Non-Invasive Vagus Nerve Stimulation Device Market Value (USD Million) By Region

Figure 15: Global Non-Invasive Vagus Nerve Stimulation Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Non-Invasive Vagus Nerve Stimulation Device Market Value (USD Million) By Region

Figure 23: Global Non-Invasive Vagus Nerve Stimulation Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-Invasive Vagus Nerve Stimulation Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-Invasive Vagus Nerve Stimulation Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-Invasive Vagus Nerve Stimulation Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Non-Invasive Vagus Nerve Stimulation Device Market Value (USD Million) By Region

Table 10: Global Non-Invasive Vagus Nerve Stimulation Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Non-Invasive Vagus Nerve Stimulation Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Non-Invasive Vagus Nerve Stimulation Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Non-Invasive Vagus Nerve Stimulation Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Cyberonics Basic Information And Sales Area

Table 31: Cyberonics. Products Portfolio

Table 32: Spark Biomedical Basic Information And Sales Area

Table 33: Spark Biomedical. Products Portfolio

Table 34: Nevro Corporation Basic Information And Sales Area

Table 35: Nevro Corporation. Products Portfolio

Table 36: Galvani Bioelectronics Basic Information And Sales Area

Table 37: Galvani Bioelectronics. Products Portfolio

Table 38: Setpoint Basic Information And Sales Area

Table 39: Setpoint. Products Portfolio

Table 40: Electrocore Basic Information And Sales Area

Table 41: Electrocore. Products Portfolio

Table 42: Livanova Basic Information And Sales Area

Table 43: Livanova. Products Portfolio

Table 44: MicroTransponder Basic Information And Sales Area

Table 45: MicroTransponder. Products Portfolio

Table 46: CVRx Basic Information And Sales Area

Table 47: CVRx. Products Portfolio

Table 48: Beijing PINS Medical Basic Information And Sales Area

Table 49: Beijing PINS Medical. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Non-Invasive Vagus Nerve Stimulation Device Market Value (USD Million) By Region

Table 55: Global Non-Invasive Vagus Nerve Stimulation Device Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Non-Invasive Vagus Nerve Stimulation Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cyberonics; Spark Biomedical; Nevro Corporation; Galvani Bioelectronics; Setpoint; Electrocore; Livanova; MicroTransponder; CVRx; Beijing PINS Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options